Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-01-22 @ 2:56 PM
Study NCT ID:
NCT04084951
Status:
COMPLETED
Last Update Posted:
2023-04-14
First Post:
2019-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
Sponsor:
SQZ Biotechnologies
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adult Solid Tumor | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent cancer | View |
| None | metastatic | View |
| None | locally advanced | View |
| None | cancer | View |
| None | cervical | View |
| None | head and neck | View |
| None | anal | View |
| None | penile | View |
| None | SQZ-PBMC-HPV | View |
| None | atezolizumab | View |
| None | HPV16 | View |
| None | APC | View |
| None | cell therapy | View |
| None | ipilimumab | View |
| None | nivolumab | View |
| None | checkpoint inhibitors | View |
| None | immunotherapy | View |
| None | solid tumor | View |
| None | HLA-A*02 | View |
| None | therapeutic vaccine | View |
| None | advanced solid tumor | View |
| None | rectal | View |
| None | vulvar | View |
| None | vaginal | View |
| None | PBMC | View |
| None | human papillomavirus strain 16 | View |
| None | peripheral blood mononuclear cells | View |
| None | antigen presenting cells | View |